Paul D. Donohoue

1.9k total citations
8 papers, 661 citations indexed

About

Paul D. Donohoue is a scholar working on Molecular Biology, Business and International Management and Biological Psychiatry. According to data from OpenAlex, Paul D. Donohoue has authored 8 papers receiving a total of 661 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 2 papers in Business and International Management and 1 paper in Biological Psychiatry. Recurrent topics in Paul D. Donohoue's work include CRISPR and Genetic Engineering (5 papers), RNA and protein synthesis mechanisms (3 papers) and Innovation and Socioeconomic Development (2 papers). Paul D. Donohoue is often cited by papers focused on CRISPR and Genetic Engineering (5 papers), RNA and protein synthesis mechanisms (3 papers) and Innovation and Socioeconomic Development (2 papers). Paul D. Donohoue collaborates with scholars based in United States, Switzerland and Egypt. Paul D. Donohoue's co-authors include Andrew P. May, Rodolphe Barrangou, Euan M. Slorach, Alexandra E. Briner, Kurt Selle, Chase L. Beisel, R.E. Haurwitz, Peter Cameron, Matthew J. Irby and Martin Jínek and has published in prestigious journals such as Cell, Molecular Cell and Biochemistry.

In The Last Decade

Paul D. Donohoue

8 papers receiving 650 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul D. Donohoue United States 7 604 96 72 61 55 8 661
Lucie Studená United Kingdom 3 358 0.6× 64 0.7× 24 0.3× 35 0.6× 61 1.1× 4 395
Ayman Eid Saudi Arabia 11 640 1.1× 81 0.8× 60 0.8× 96 1.6× 400 7.3× 14 708
Christopher M. Whitford Denmark 8 342 0.6× 63 0.7× 15 0.2× 38 0.6× 41 0.7× 12 380
Agnieszka Piatek United States 12 634 1.0× 64 0.7× 34 0.5× 72 1.2× 401 7.3× 15 717
Ana Paula Mulet Uruguay 7 401 0.7× 229 2.4× 33 0.5× 16 0.3× 41 0.7× 13 520
Madhab Kumar Sen Czechia 10 277 0.5× 48 0.5× 19 0.3× 23 0.4× 149 2.7× 26 412
Minhee Jung South Korea 7 971 1.6× 121 1.3× 110 1.5× 189 3.1× 495 9.0× 10 1.1k
Jiacheng Hu China 9 349 0.6× 36 0.4× 18 0.3× 61 1.0× 222 4.0× 21 467
Yao He China 11 786 1.3× 107 1.1× 77 1.1× 113 1.9× 530 9.6× 18 868
Yanjun He China 17 734 1.2× 48 0.5× 20 0.3× 74 1.2× 881 16.0× 26 1.1k

Countries citing papers authored by Paul D. Donohoue

Since Specialization
Citations

This map shows the geographic impact of Paul D. Donohoue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul D. Donohoue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul D. Donohoue more than expected).

Fields of papers citing papers by Paul D. Donohoue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul D. Donohoue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul D. Donohoue. The network helps show where Paul D. Donohoue may publish in the future.

Co-authorship network of co-authors of Paul D. Donohoue

This figure shows the co-authorship network connecting the top 25 collaborators of Paul D. Donohoue. A scholar is included among the top collaborators of Paul D. Donohoue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul D. Donohoue. Paul D. Donohoue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Lin, Chun‐Han, Antoine Cléry, Aakash Saha, et al.. (2022). Structural basis for Cas9 off-target activity. Cell. 185(22). 4067–4081.e21. 117 indexed citations
2.
Garner, Elizabeth, Paul D. Donohoue, Mara Bryan, et al.. (2022). Abstract LB009: A BCMA-specific allogeneic CAR-T cell therapy (CB-011) genome-engineered to express an HLA-E fusion transgene to prevent immune cell rejection. Cancer Research. 82(12_Supplement). LB009–LB009. 1 indexed citations
3.
Donohoue, Paul D., Martin Pačesa, Elaine K. Lau, et al.. (2021). Conformational control of Cas9 by CRISPR hybrid RNA-DNA guides mitigates off-target activity in T cells. Molecular Cell. 81(17). 3637–3649.e5. 42 indexed citations
4.
Amrani, Nadia, Xin D. Gao, Pengpeng Liu, et al.. (2018). NmeCas9 is an intrinsically high-fidelity genome-editing platform. Genome biology. 19(1). 214–214. 96 indexed citations
5.
Donohoue, Paul D., Rodolphe Barrangou, & Andrew P. May. (2017). Advances in Industrial Biotechnology Using CRISPR-Cas Systems. Trends in biotechnology. 36(2). 134–146. 161 indexed citations
6.
Briner, Alexandra E., Paul D. Donohoue, Kurt Selle, et al.. (2014). Guide RNA Functional Modules Direct Cas9 Activity and Orthogonality. Molecular Cell. 56(2). 333–339. 191 indexed citations
7.
Gay, Sean C., Jennifer L. Fribourgh, Paul D. Donohoue, Irwin H. Segel, & Andrew J. Fisher. (2009). Kinetic properties of ATP sulfurylase and APS kinase from Thiobacillus denitrificans. Archives of Biochemistry and Biophysics. 489(1-2). 110–117. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026